• 4 hospitals sign 5-year capital licence agreements for Mach7's PACS solution
• New 3-year Blackford AI platform subscription licence for the Veterans Health Administration (VHA) National Teleradiology Program (NTP)
• These agreements are expected to add A$0.8M to Contracted Annual Recurring Revenue (CARR) at 31 December 2024

Mach7 Technologies Limited (ASX:M7T) has announced that it has signed four new contracts for its PACS solution and received a new sales order for the Veterans Health Administration (VHA) National Teleradiology Program (NTP). The company has signed capital licence agreements with four hospitals associated with Adventist Health, a non-profit integrated health system serving more than 80 communities on the West Coast of the United States and Hawaii. These 5-year agreements have a combined Total Contract Value (TCV) of A$2.5M, with Mach7 providing a full PACS solution including its eUnity Viewer and Vendor Neutral Archive (VNA). Mach7 has also received an additional sales order for the Blackford AI platform for the VHA NTP Phase I NextGen PACS program. This subscription licence has a potential TCV of A$2.1M based on a fee per study over a three-year term. These agreements are expected to add a combined A$0.8M to Contracted Annual Recurring Revenue (CARR) at 31 December 2024. CEO of Mach7 Mike Lampron stated that these agreements demonstrate Mach7's strengths in complex reading environments and the merits of its diverse product offering, with clients finding value in its components individually or as a tech stack.

Mach7 reaffirms its FY25 guidance for CARR and revenue growth of 15-25% and for opex growth to be less than revenue growth.